New Key Statistics Module, Z-Score and F-Score
NAS:TRAW Key Ratios
| Market Cap $ M | 10.63 |
| Enterprise Value $ M | -5.51 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.45 |
| Price/Sales | 35.20 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.87 |
| Beneish M-Score | -2.84 |
| 10-y EBITDA Growth Rate % | 67.00 |
| 5-y EBITDA Growth Rate % | 60.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.28 |
| EV-to-EBITDA | 0.28 |
| PEG | -- |
| Shares Outstanding M | 25.31 |
| Net Margin (%) | -8,033.63 |
| Operating Margin % | -8,572.12 |
| Pre-tax Margin (%) | -8,033.63 |
| Quick Ratio | 1.93 |
| Current Ratio | 1.93 |
| ROA % (ttm) | -68.04 |
| ROE % (ttm) | -124.39 |
| ROIC % (ttm) | -1,940.79 |
| Dividend Yield % | -- |
| Altman Z-Score | -39.74 |
TRAW Number of Guru Trades
TRAW Volume of Guru Trades
Gurus Latest Trades with NAS:TRAW
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TRAW is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Traws Pharma Inc Insider Transactions
No Available Data
News about NAS:TRAW
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers